Your browser doesn't support javascript.
loading
Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study).
Fountoulakis, Konstantinos N; Karakatsoulis, Grigorios N; Abraham, Seri; Adorjan, Kristina; Ahmed, Helal Uddin; Alarcón, Renato D; Arai, Kiyomi; Auwal, Sani Salihu; Berk, Michael; Bjedov, Sarah; Bobes, Julio; Bobes-Bascaran, Teresa; Bourgin-Duchesnay, Julie; Bredicean, Cristina Ana; Bukelskis, Laurynas; Burkadze, Akaki; Cabrera Abud, Indira Indiana; Castilla-Puentes, Ruby; Cetkovich, Marcelo; Colon-Rivera, Hector; Corral, Ricardo; Cortez-Vergara, Carla; Crepin, Piirika; De Berardis, Domenico; Zamora Delgado, Sergio; Lucena, David De; Sousa, Avinash De; Stefano, Ramona Di; Dodd, Seetal; Priyanka Elek, Livia; Elissa, Anna; Erdelyi-Hamza, Berta; Erzin, Gamze; Etchevers, Martin J; Falkai, Peter; Farcas, Adriana; Fedotov, Ilya; Filatova, Viktoriia; Fountoulakis, Nikolaos K; Frankova, Iryna; Franza, Francesco; Frias, Pedro; Galako, Tatiana; Garay, Cristian J; Garcia-Álvarez, Leticia; García-Portilla, Maria Paz; Gonda, Xenia; Gondek, Tomasz M; Morera González, Daniela; Gould, Hilary.
Afiliação
  • Fountoulakis KN; 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki Greece, Thessaloniki, Greece.
  • Karakatsoulis GN; 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki Greece, Thessaloniki, Greece.
  • Abraham S; Pennine Care NHS Foundation Trust, Heywood, UK.
  • Adorjan K; Manchester Metropolitan University, Manchester, UK.
  • Ahmed HU; Core Psychiatry Training, Health Education England North West, Manchester, UK.
  • Alarcón RD; Department of Psychiatry, Ludiwig-Maximilians-University, Munich, Germany.
  • Arai K; Child Adolescent and Family Psychiatry, National Institute of Mental Health, Dhaka, Bangladesh.
  • Auwal SS; Section of Psychiatry and Mental Health, Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado, Lima, Peru.
  • Berk M; Department of Psychiatry and Psychology, Mayo Clinic School of Medicine, Rochester, MN, USA.
  • Bjedov S; School of Medicine and Health Science, Institute of Health Science Shinshu University, Matsumoto, Japan.
  • Bobes J; Department of Psychiatry, Bayero University, Kano, Nigeria.
  • Bobes-Bascaran T; Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Bourgin-Duchesnay J; IMPACT - The Institute for Mental and Physical Health and Clinical Translation, Deakin University, School of Medicine, Barwon Health, Geelong, Australia.
  • Bredicean CA; Orygen The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia.
  • Bukelskis L; Department of Psychiatry and Psychological Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Burkadze A; Psychiatry Area, Department of Medicine, University of Oviedo, Oviedo, Spain.
  • Cabrera Abud II; Department of Psychiatry, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Castilla-Puentes R; ISPA, INEUROPA, CIBERSAM, Oviedo, Spain.
  • Cetkovich M; ISPA, INEUROPA, CIBERSAM, Oviedo, Spain.
  • Colon-Rivera H; Mental Health Center of La Corredoria, Oviedo, Spain.
  • Corral R; Department of Psychology, University of Oviedo, Oviedo, Spain.
  • Cortez-Vergara C; Division of Child and Adolescent Psychiatry, Department of Psychiatry, Groupe Hospitalier Nord Essonne, Orsay, France.
  • Crepin P; Department of Neuroscience, Discipline of Psychiatry, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
  • De Berardis D; Clinic of Psychiatry, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
  • Zamora Delgado S; Mental Hub, Tbilisi, Georgia.
  • Lucena D; NGO Healthcare Research and Quality Agency, Tbilisi, Georgia.
  • Sousa A; Hospital San Juan de Dios Hospital, Guadalajara, Mexico.
  • Stefano RD; Janssen Research and Development, Johnson & Johnson, American Society of Hispanic Psychiatry and WARMI Women Mental Health, Cincinnati, OH, USA.
  • Dodd S; Institute of Translational and Cognitive Neuroscience (INCyT), INECO Foundation, Favaloro University, Buenos Aires, Argentina.
  • Priyanka Elek L; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.
  • Elissa A; APM Board Certified in General Psychiatry and Neurology, Addiction Psychiatry, & Addiction Medicine, UPMC, DDAP, Philadelphia, PA, USA.
  • Erdelyi-Hamza B; Department of Teaching and Research, Hospital Borda, Buenos Aires, Argentina.
  • Erzin G; University of Buenos Aires, Buenos Aires, Argentina.
  • Etchevers MJ; Universidad Peruana Cayetano Heredia, Clínica AngloAmericana, Lima, Peru.
  • Falkai P; Sanitaire and Social Union for Accompaniment and Prevention, Center of Ambulatory Psychiatry of Narbonne and Lezigan, Narbonne, France.
  • Farcas A; Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital "G. Mazzini", ASL Teramo, Teramo, Italy.
  • Fedotov I; School of Nursing, University of L'Aquila, Italy.
  • Filatova V; Department of Neuroscience and Imaging, School of Psychiatry, University of Chieti, Chieti, Italy.
  • Fountoulakis NK; Child and Adolescent Psychiatry Department, Hospital Luis Calvo Mackenna, Santiago, Chile.
  • Frankova I; Departamento de Fisiología e Farmacología, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil.
  • Franza F; Department of Psychiatry, Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India.
  • Frias P; Desousa Foundation, Mumbai, Maharashtra, India.
  • Galako T; Department of Biotechnological and Applied Clinical Sciences, Section of Psychiatry, University of L'Aquila, L'Aquila, Italy.
  • Garay CJ; IMPACT - The Institute for Mental and Physical Health and Clinical Translation, Deakin University, School of Medicine, Barwon Health, Geelong, Australia.
  • Garcia-Álvarez L; Orygen The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia.
  • García-Portilla MP; University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia.
  • Gonda X; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
  • Gondek TM; Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia.
  • Morera González D; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
  • Gould H; Department of Psychiatry, Ankara Diskapi Training and Research Hospital, Ankara, Turkey.
CNS Spectr ; 29(2): 126-149, 2024 04.
Article em En | MEDLINE | ID: mdl-38269574
ABSTRACT

BACKGROUND:

The prevalence of medical illnesses is high among patients with psychiatric disorders. The current study aimed to investigate multi-comorbidity in patients with psychiatric disorders in comparison to the general population. Secondary aims were to investigate factors associated with metabolic syndrome and treatment appropriateness of mental disorders.

METHODS:

The sample included 54,826 subjects (64.73% females; 34.15% males; 1.11% nonbinary gender) from 40 countries (COMET-G study). The analysis was based on the registration of previous history that could serve as a fair approximation for the lifetime prevalence of various medical conditions.

RESULTS:

About 24.5% reported a history of somatic and 26.14% of mental disorders. Mental disorders were by far the most prevalent group of medical conditions. Comorbidity of any somatic with any mental disorder was reported by 8.21%. One-third to almost two-thirds of somatic patients were also suffering from a mental disorder depending on the severity and multicomorbidity. Bipolar and psychotic patients and to a lesser extent depressives, manifested an earlier (15-20 years) manifestation of somatic multicomorbidity, severe disability, and probably earlier death. The overwhelming majority of patients with mental disorders were not receiving treatment or were being treated in a way that was not recommended. Antipsychotics and antidepressants were not related to the development of metabolic syndrome.

CONCLUSIONS:

The finding that one-third to almost two-thirds of somatic patients also suffered from a mental disorder strongly suggests that psychiatry is the field with the most trans-specialty and interdisciplinary value and application points to the importance of teaching psychiatry and mental health in medical schools and also to the need for more technocratically oriented training of psychiatric residents.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos / Síndrome Metabólica / Transtornos Mentais Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: CNS Spectr Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos / Síndrome Metabólica / Transtornos Mentais Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: CNS Spectr Ano de publicação: 2024 Tipo de documento: Article